These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4828628)

  • 1. A new low-oestrogen, low-progestogen combined oral contraceptive.
    Woutersz TB
    Curr Med Res Opin; 1974; 2(2):95-100. PubMed ID: 4828628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
    Gaspard UJ; Deville JL; Dubois M
    Curr Med Res Opin; 1983; 8(6):395-404. PubMed ID: 6406157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical assessment of a low-dose oestrogen, low-dose progestogen combined oral contraceptive.
    Allen HH
    Curr Med Res Opin; 1974; 2(2):101-8. PubMed ID: 4828625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance.
    Endrikat J; Müller U; Düsterberg B
    Contraception; 1997 Mar; 55(3):131-7. PubMed ID: 9115000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical assessment of a low-oestrogen combined oral contraceptive.
    Bye PG; Elstein M
    Br Med J; 1973 May; 2(5863):389-92. PubMed ID: 4574044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestogen-only microdose followed by estrogen-progestogen combination, a new approach to oral contraception.
    Russowsky M; Sartoretto JN
    Contraception; 1982 Jul; 26(1):41-9. PubMed ID: 7128133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version.
    Carlborg L
    Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles.
    Bannemerschult R; Hanker JP; Wünsch C; Fox P; Albring M; Brill K
    Contraception; 1997 Nov; 56(5):285-90. PubMed ID: 9437556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.
    Koetsawang S; Charoenvisal C; Banharnsupawat L; Singhakovin S; Kaewsuk O; Punnahitanont S
    Contraception; 1995 Apr; 51(4):225-9. PubMed ID: 7796587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cycle control with triphasic norgestimate and ethinyl estradiol, a new oral contraceptive agent.
    Andolsek KM
    Acta Obstet Gynecol Scand Suppl; 1992; 156():22-6. PubMed ID: 1324553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of a new oral contraceptive, 'Pregnon'.
    van de Walle J; Weijers MJ
    Curr Med Res Opin; 1975; 3(3):151-6. PubMed ID: 1149483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical studies with a low dose estrogen-progestogen combination.
    Sartoretto JN; Ortega-Recio JC; Moraes R; Filho FN
    Contraception; 1977 May; 15(5):563-70. PubMed ID: 880827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel.
    Rekers H
    Acta Obstet Gynecol Scand; 1988; 67(2):171-4. PubMed ID: 2972160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES; Cruickshank J; McMaster M; Weir RJ
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with a triphasic oral contraceptive.
    Ulstein M; Svendsen E; Steier A; Bratt H; Fylling P; Lie S; Schiefloe A; Aaserud J
    Acta Obstet Gynecol Scand; 1984; 63(3):233-6. PubMed ID: 6428157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with a low dose oral contraceptive containing norethisterone and ethinyl oestradiol.
    Morigi EM; Pasquale SA
    Curr Med Res Opin; 1978; 5(8):655-62. PubMed ID: 710178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with ethinyl estradiol and d-norgestrel as an oral contraceptive.
    Apelo R; Veloso I
    Fertil Steril; 1975 Mar; 26(3):283-8. PubMed ID: 1116622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of low-dose progestogen-estrogen combination (WL-20) on the menstrual cycle of sexually active women of childbearing age.
    Sartoretto JN; Moraes R
    Contraception; 1974 Aug; 10(2):127-34. PubMed ID: 4418507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.